Genemo (United States)
SAN DIEGO – Researchers at the UCSD in collaboration with Genemo discovered that high blood levels of RNA produced by the PHGDH gene could serve as a biomarker for early detection of Alzheimer's disease. NEW YORK – Genemo, a California startup, has launched an extracellular RNA sequencing service that it hopes to develop into companion diagnostics. BEING PATIENT – Researchers discovered a new biomarker associated with Alzheimer’s disease—high blood levels of RNA from a gene known as PHGDH.
Basic Information
- Category: business
- Founded: 2015
- Website: https://rnadiagnosis.com/
Documented Facts
- Email: info@rnadiagnosis.com (No linked source recorded for this statement.)
- Founded: 2015 (No linked source recorded for this statement.)
- Website: https://rnadiagnosis.com/ (No linked source recorded for this statement.)
- Country: United States (No linked source recorded for this statement.)
Evidence and Sources
- Genemo (United States) — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Genemo (United States).
- Canonical profile: https://brandsource.ai/brands/genemo-united-states
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/genemo-united-states/json-ld
- Citation profile API: https://brandsource.ai/api/brands/genemo-united-states/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (86/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
SAN DIEGO – Researchers at the UCSD in collaboration with Genemo discovered that high blood levels of RNA produced by the PHGDH gene could serve as a biomarker for early detection of Alzheimer's disease. NEW YORK – Genemo, a California startup, has launched an extracellular RNA sequencing service that it hopes to develop into companion diagnostics. BEING PATIENT – Researchers discovered a new biomarker associated with Alzheimer’s disease—high blood levels of RNA from a gene known as PHGDH.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 4 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.